Application in progress. VolDesk Analytics has applied for registration as a Research Analyst with SEBI. We are not currently offering, soliciting or providing research services, and no subscriptions are being accepted. The content on this site is general market commentary for information only.
SEBI RESEARCH ANALYST REGISTRATION — APPLICATION SUBMITTED STATUS: PENDING NISM SERIES XV: CERTIFIED
← Back to articles

03 Aug 2026 · Chirag Asnani

Indo-MIM's 44% Pop: Will the Hype Hold, or Will Valuation Have the Last Word?

Few Indian listings this year have been as loud as Indo-MIM Limited. The world's largest metal-injection-moulding (MIM) manufacturer priced its IPO at ₹485, drew a 72.4x subscription, and opened on 30 July 2026 at ₹700 — a 44.3% listing gain. Since then it has drifted higher, trading around ₹769 by 3 August, roughly 59% above the issue price and valuing the company near ₹35,000–38,000 crore. The obvious question for anyone watching the screen is simple: is this the market correctly re-rating a rare, high-quality manufacturer — or a listing-day mood that valuation will eventually catch up with?

What the market is paying for today

Indo-MIM is a genuinely strong franchise. In FY26 it earned ₹4,193 crore of revenue (a 20.9% three-year CAGR), a 25.5% EBITDA margin, 21% return on equity and 27% return on capital employed, with net debt of only 0.65x EBITDA. It serves 1,100-plus global OEMs across automotive, defence, medical, consumer and aerospace, and roughly 80% of revenue is repeat business. Quality is not the debate.

Price is. At ~₹769 the stock carries the following multiples:

MeasureAt ~₹769Context
Trailing P/E (FY26)~71xIPO was priced at ~44.6x FY26 earnings
Forward P/E (FY27E)~59xon ~₹13 estimated EPS
EV / EBITDA (FY26)~36xvs 0.65x net-debt/EBITDA balance sheet
Price / Book~13.5xon FY26 net worth

Put plainly: even the IPO price of ₹485 already embedded a premium multiple. The listing pop and subsequent drift have pushed the trailing earnings multiple from the mid-40s to roughly 71x. That is a lot of future baked into today's price.

The case for the premium holding

There is a coherent bull argument, and it deserves a fair hearing. MIM is a niche, high-barrier technology that steadily displaces conventional machining and casting for small, complex parts; the global market (about USD 4.0 billion in CY25) is compounding near 9% a year. Indo-MIM is the volume leader, with sticky OEM relationships, multi-year qualification cycles and rising exposure to structurally growing end-markets — aerospace and defence, plus a fast-growing India book. Indian public markets have also, for several years, awarded scarce, high-return manufacturing and defence-linked names a substantial premium over global peers. If that "India manufacturing premium" persists and the company keeps compounding earnings near 17–20%, a rich multiple can stay rich for a long time.

What history and peers whisper back

The counter-argument is equally grounded. Listing-day premiums on heavily-subscribed, richly-priced IPOs have a long habit of fading once the euphoria and anchor flows normalise — the re-rating often happens through time (a stock going nowhere while earnings catch up) rather than a dramatic fall. And when you widen the lens to how comparable businesses are priced outside India, the gap is striking:

CohortTypical EV/EBITDA
Indo-MIM at ~₹769~36x
Global listed precision-manufacturing index (May 2026)~17x
Scaled aerospace/defence precision shops (private M&A)9–11x
General precision-machining businesses (private M&A)5–8x

Indo-MIM's only listed pure-play peer, China's Jiangsu Gian Technology (Shenzhen), operates on thinner ~15% EBITDA margins and a low-single-digit return on equity — better profitability is exactly what justifies Indo-MIM trading above that peer, but not necessarily at double the multiple of the entire global listed precision cohort. In other words, part of the premium is quality; the rest is domestic sentiment.

A fair-value frame

Our companion valuation note works the problem from two directions. A three-stage discounted-cash-flow model (FCFF, ~12.9% WACC, 5% terminal growth) captures the fact that Indo-MIM reinvests heavily in capex and working capital, so its free-cash conversion is modest — that lens produces a base intrinsic value near ₹245. A relative lens, applying growth-and-quality multiples (~38x forward earnings, ~22x EV/EBITDA) to FY27 estimates, lands closer to ₹500–530. Blending the two gives a central fair value around ₹390, with a scenario band of roughly ₹310 (cautious) to ₹490 (optimistic).

The uncomfortable takeaway: across intrinsic and relative methods, and even under fairly generous growth assumptions, our fair-value band sits below the current ₹769. On the base case, the price effectively pre-pays around three years of earnings growth.

That does not make the shares "wrong" — it makes them expensive relative to modelled value, which is a different statement. The whole debate hinges on one variable: whether the market keeps paying a premium multiple for the franchise. If it does, the stock can stay elevated. If sentiment normalises toward how the rest of the world prices precision manufacturers, valuation gravity does the talking.

So — hype, or repricing?

Both can be true in sequence. Indo-MIM is a high-quality, structurally-growing business that genuinely merits a premium to its global peer set. It is also, at ~71x trailing earnings and ~36x EV/EBITDA, priced for a near-flawless multi-year execution — leaving little margin for the export, tariff, cyclical and mix risks that come with a company earning three-quarters of its revenue abroad. History suggests the most likely resolution is not a headline crash but a de-rating over time, as earnings grow into the price and the multiple drifts back toward what quality alone can defend. For readers, the useful discipline is to separate the two questions the market keeps blurring: is this a good company? (clearly yes) and is this a good price? (a much closer call). The gap between ₹390 and ₹769 is the market's current answer to the second question — and the number worth watching as the hype settles.

References & further reading

Disclosure — Educational market commentary only. Not a recommendation to deal in any security. Figures are drawn from the company prospectus and public sources as at the date of publication and may change. This article is for information and education only and does not constitute personalised advice. Investments in securities are subject to market risk; no returns are assured.